Autor: Medical Econet
03.01.2017
Autor: Medical Econet
03.01.2017
Zum 1. Januar 2017 treten im Bereich Gesundheit und Pflege wichtige Änderungen in Kraft. Im folgenden Artikel finden Sie all dazu benötigen Informationen.
Das am 1. Januar 2016 in Kraft getretene Zweite Pflegestärkungsgesetz schaffte die rechtlichen Grundlagen für die Vorbereitung des neuen Begutachtungsverfahrens und der Umstellung auf Pflegegrade und neue Leistungsbeträge.
“Wir haben uns in der Pflege einen echten Kraftakt vorgenommen und können jetzt sagen: 2017 wird ein gutes Jahr für Pflegebedürftige und ihre Familien sowie unsere Pflegekräfte. Zehn Jahre wurde geredet. Jetzt wird der neue Pflegebedürftigkeitsbegriff endlich Wirklichkeit. Die Experten sind sich einig, dass der Unterstützungsbedarf der Pflegebedürftigen damit besser erfasst werden kann. Die Leistungen werden passgenauer auf die Bedürfnisse der Pflegebedürftigen zugeschnitten. Das wird viele Familien entlasten. Demenzkranke erhalten endlich einen gleichberechtigten Zugang zu allem Unterstützungsangeboten. Außerdem setzt die Hilfe künftig deutlich früher ein und steigt mit wachsendem Unterstützungsbedarf. Dadurch erhalten viele Pflegebedürftige erstmals Leistungen der Pflegeversicherung. Insgesamt stehen für die Pflege fünf Milliarden zusätzlich pro Jahr zur Verfügung.
Die wichtigsten Regelungen ab 1. Januar 2017 sind:
Pflegegrad (PG) | Geldleistung ambulant (Pflegegeld) | Sachleistung ambulant | Leistungsbetrag vollstationär |
---|---|---|---|
PG1 | 125* | – | 125 |
PG2 | 316 | 689 | 770 |
PG3 | 545 | 1298 | 1262 |
PG4 | 728 | 1612 | 1775 |
PG5 | 901 | 1995 | 2005 |
*Hier keine Geldleistung, sondern eine zweckgebundene Kostenerstattung
Damit Pflegebedürftige und ihre Angehörigen sowie Menschen, die künftig Hilfe benötigen, sich gut über die Leistungen der Pflegeversicherung informieren können, wird die Pflegeberatung gestärkt und die Zusammenarbeit der Verantwortlichen in den Kommunen ausgebaut. Das Gesetz ist ein weiterer Baustein für eine bessere Bezahlung der Altenpflegekräfte. Außerdem werden die Kontrollmöglichkeiten ausgebaut, um Pflegebetrug noch wirksamer zu verhindern und Pflegebedürftige, ihre Angehörigen, aber auch die Versichertengemeinschaft noch besser davor zu schützen. Die wichtigsten Regelungen des Gesetzes sind:
Das Gesetz enthält eine Vielzahl von Einzelregelungen, die unterschiedliche Bereiche des Arzneimittelrechts betreffen. Die wichtigsten Regelungen sind:
(Ausfertigung und Verkündung stehen noch aus)
Um den Bedürfnissen seelisch kranker Menschen in der medizinischen Behandlung besser gerecht zu werden, wird das Vergütungssystem für psychiatrische und psychosomatische Leistungen angepasst: Behandlungen mit hohem Aufwand sollen künftig besser vergütet werden als weniger aufwändige. Mit Mindestpersonalvorgaben soll die menschliche Zuwendung gestärkt werden. Außerdem werden ambulante und stationäre Leistungen enger verzahnt, um die Versorgung der Patienten weiter zu stärken. Die wichtigsten Regelungen sind:
Der vom BMG festgesetzte durchschnittliche Zusatzbeitragssatz in der gesetzlichen Krankenversicherung (GKV) für das Jahr 2017 bleibt stabil und liegt weiterhin bei 1,1 Prozent.
Seine Höhe wird jährlich aus der Differenz der vom Schätzerkreis prognostizierten Einnahmen und Ausgaben der GKV im kommenden Jahr errechnet. Wie hoch der individuelle Zusatzbeitragssatz einer Krankenkasse für ihre Mitglieder tatsächlich ausfällt, legt die jeweilige Krankenkasse selbst fest. Er richtet sich unter anderem danach, wie wirtschaftlich eine Krankenkasse arbeitet, über welche Finanzreserven sie verfügt und welche weiteren Leistungen sie anbietet. Erhöht eine Krankenkasse ihren kassenindividuellen Zusatzbeitrag, haben die Mitglieder ein Sonderkündigungsrecht und können in eine andere Krankenkasse wechseln. Eine Übersicht über die jeweils aktuelle Höhe der kassenindividuellen Zusatzbeiträge ist auf der Seite des GKV-Spitzenverbandes abrufbar.
Die mit dem E-Health-Gesetz beschlossene Regelung entlastet die Bezieher einer gesetzlichen Waisenrente oder einer vergleichbaren Leistung eines berufsständischen Versorgungswerkes:
Zur weiteren Verbesserung der Patienten- und Anwendersicherheit ist die Medizinprodukte-Betreiberverordnung grundlegend überarbeitet worden. In der Medizinprodukte-Verordnung und in der Medizinprodukte-Sicherheitsplanverordnung werden wichtige Vorschriften neu gefasst.
Die wichtigsten Änderungen sind:
Mit dem Gesetz zur Stärkung der Versorgung in der gesetzlichen Krankenversicherung (GKV–VSG) wurden die Regelungen zu den Wirtschaftlichkeitsprüfungen neu strukturiert, damit regionale Gegebenheiten stärker als bisher berücksichtigt werden können. Ab 2017 wird die Wirtschaftlichkeit der Versorgung mit ärztlich verordneten Leistungen grundsätzlich anhand von Vereinbarungen der Selbstverwaltungspartner auf Landesebene geprüft.
Das Gesetz ist ein wichtiger Beitrag zur weiteren Verbesserung der Sicherheit von menschlichen Gewebezubereitungen für Patientinnen und Patienten.
Autor: https://www.bundesgesundheitsministerium.de/ministerium/meldungen/2016/neuregelungen-2017.html
29.12.2016
Wir möchten Sie recht herzlich in das neueröffnender Büro in wunderschönem Berlin einladen . Wir freuen uns sehr auf Ihren Besuch und stehen Ihnen stets zur Verfügung.
Euer P&P CITO TEAM
Autor:
21.11.2016
Call for expression of interest for experts in the area of safety of surgical meshes used in urogynecological surgery
The European Commission has requested the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), to deliver an opinion on the safety of surgical meshes used in urogynecological surgery.
To enable a comprehensive assessment in this area, SCENIHR has identified a need for experts to constitute the relevant working group who will help the Committee on this opinion, in the following areas: gynaecology, surgery, biocompatibility, urology and oncology.
Following the Rules of procedure of the Scientific Committees, a call for expression of interest for experts with outstanding background in the areas mentioned above is launched. International experts are also encouraged to apply.
The deadline for submission for this call for experts is 10 April 2014.
Interested experts can submit their application through the database of experts which can be found here.
In addition to this, interested experts have to send the application form and their CV to the functional email box: SANCO-C2-SCIENTIFIC-COMMITTEES@ec.europa.eu indicating “Surgical Meshes – call for experts” in the subject title of the e-mail.
The successful candidate will be required to read and accept the conditions for his/her membership in the working group, as explained in detail in the Rules of procedure of the Scientific Committees.
Author: http://ec.europa.eu/health/scientific_committees/consultations/calls_experts/scenihr_exp_08_en.htm
published: 24/03/2014
Health Expert Panel adopts first three opinions
The independent Expert Panel which advises the Commission on matters related to “effective ways of investing in health” has adopted its first three opinions, which were published today.
The first opinion on a frame of reference in relation to primary care with a special emphasis on financing systems and referral systems is of particular interest to EU countries that are making efforts to improve the functioning and sustainability of their health systems. The opinion provides a core definition of primary care, underlines its importance, and recommends its strengthening in terms of infrastructures, organisation, access, and financing. A public consultation on this opinion will be launched soon.
The second opinion on Criteria to identify priority areas when assessing the performance of health systems has a practical aim. The Expert Panel has elaborated guidance on elements to be considered when developing such criteria.
The third opinion is an assessment of the study “Evaluation of public-private partnerships in health care delivery across the EU”. The opinion provides a critical peer review of a much debated topic. It examines the strength of the evidence and assesses the conclusions of the study.
These opinions, as all advice given by the Expert Panel on effective ways of investing in Health, are non-binding.
Author: http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1464
published: 20/03/2014
Author: http://www.ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?List=8db7286c-fe2d-476c-9133-18ff4cb1b568&ID=1080
published: 14.10.2014
Health Expert Panel adopts first three opinions
The independent Expert Panel which advises the Commission on matters related to “effective ways of investing in health” has adopted its first three opinions, which were published today.
The first opinion on a frame of reference in relation to primary care with a special emphasis on financing systems and referral systems is of particular interest to EU countries that are making efforts to improve the functioning and sustainability of their health systems. The opinion provides a core definition of primary care, underlines its importance, and recommends its strengthening in terms of infrastructures, organisation, access, and financing. A public consultation on this opinion will be launched soon.
The second opinion on Criteria to identify priority areas when assessing the performance of health systems has a practical aim. The Expert Panel has elaborated guidance on elements to be considered when developing such criteria.
The third opinion is an assessment of the study “Evaluation of public-private partnerships in health care delivery across the EU”. The opinion provides a critical peer review of a much debated topic. It examines the strength of the evidence and assesses the conclusions of the study.
These opinions, as all advice given by the Expert Panel on effective ways of investing in Health, are non-binding.
Author: http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1464
published: 20.03.2014
About the fair
SALMED, Poland’s largest trade fair of medical equipment, will once again gather together leaders of the medical market. The upcoming edition of the event is scheduled to take place on the premises of Międzynarodowe Targi Poznańskie on 10-12 February 2014, creating a great opportunity for the exchange of knowledge and experiences, and for forging relations between representatives of medicine, business and science.
Professional and modern
SALMED International Trade Fair of Medical Equipment and Instruments, held on a biennial basis, is Poland’s largest venue for presenting products offered by manufacturers and suppliers of medical devices and instruments, equipment for hospitals, clinics and private medical practices, as well as laboratory companies and firms supplying rehabilitation equipment.
Presentation of the newest products
One of the additional possibilities offered to Exhibitors during the fair is the presentation of their newest products, technologies and services. It is an excellent form of promotion and prominent display of products that are new on the market and those that make their debut at the fair.
New products are the driving force of technological development in every industry, which is why they are a very valuable addition to the trade fair offer. Products shown to professional audience are sure to be appreciated. Products debuting at the trade fair will be showcased in specially marked exhibitors’ stands, which guarantees their high recognition among visitors as well as published in trade fair guides, press materials and on the fair’s website.
Medical know-how: a rich programme of seminars and conferences
An indispensable element of the SALMED fair is a program of seminars and specialist conferences, along with workshops, lectures and many business meetings. The thematic scope of SALMED comprises several conference modules: Management, Emergency Medicine, Rehabilitation Laboratory, Nursing and others.
Professional visitors
An extensive programme of scientific events is targeted at those visitors who are professionally involved in the medical industry.
The majority of SALMED visitors are medical industry professionals:
healthcare managers
directors of medical facilities
representatives of the state and local authorities
physicians
laboratory diagnosticians
rehabilitation and physiotheraphy specialists
medical rescue personnel
nurses and midwives
medical staff
medicine students
Author: http://www.salmed.pl/en/salmed_in_a_nutshell/about_the_fair/
04.02.2014
The Arab Health Exhibition and Congress attracts a wide range of visitors across the spectrum of healthcare including: medical manufacturers, general practitioners, hospital doctors, hospital managers, hospital nursing staff, hospital technical managers, laboratory managers, physiotherapists, medical assistants and dealers and distributors.
Each year, Arab Health becomes an even more international event, attracting healthcare and medical professionals from the region as well as from across the globe. In 2012, more than 83,000 visitors came from 142 countries, proving that Arab Health is truly where the healthcare world comes to do business.
Should you attend Arab Health 2013?
Arab Health is for all healthcare professionals across the globe.
Our visitors span from nurses in local hospitals to CEOs of multi-national healthcare companies.
We have 1000s of people visiting, with 1000s of different job titles, but we have listed a selection below of our most frequent visitors:
Author: http://www.arabhealthonline.com/en/Welcome/
28.01.2014
European citizens, no matter where they live, have the right to choose where to receive medical treatment across the EU, and to be reimbursed for it. This right is now spelled out in the Directive on Cross-Border Healthcare pdfwhich enters into force in the whole European Union on 25 October 2013.
Author: ec.europa.eu/health
25.10.2013
„I welcome the positive vote in today’s European Parliament plenary in favour of engaging in negotiations with the Council. We have witnessed a lively and thorough debate on the Commission’s proposal for the revision of the Tobacco Products proposal, and I would like to thank the MEPs for their support and to pay a special tribute to the rapporteur – Linda McAvan – for her commitment, determination, and important contribution towards securing this favourable vote.
It’s not the end of the road but this will allow us to take the process of negotiations forward and to engage with Council in order to come to a meaningful agreement on the file.
Indeed, the Commission will now carefully analyse the amendments adopted today, and define our position, so that negotiations can continue in trilogue. I am confident that the revised Directive on Tobacco Products can still be adopted within the mandate of the current Parliament. All institutional actors have to play their role since EU citizens expect all of us to act on tobacco and to adopt in the near future a new legislation which will put the EU on the frontline on a global stage”.
Author: http://europa.eu/rapid/press-release_MEMO-13-859_en.htm
18.10.2013
On 6 October, Spanish authorities confirmed infection with Ebola virus disease (EVD) in a healthcare worker who participated in the treatment of the second Spanish Ebola patient who was repatriated to Spain. The infected healthcare worker represents the first transmission of Ebola infection in the European Union.
„It is our mandate to re-assess the risk to the EU”, says ECDC Director Marc Sprenger, “and we are confident that infection control protocols in Europe are of high standard and remain appropriate if strictly adhered to. But there is no such thing as a zero per cent risk of infection. It is important to understand that the risk of Ebola to Europe can only be eliminated by stopping the outbreak in West Africa.”
Two ECDC experts are currently in Madrid to support the local authorities in their investigations of the mechanism through which the nurse has been infected. Once this information is available, ECDC will consider the possible implications on the transmission risk to Europe in its updated risk assessment.
Published: 14/10/2014
„I welcome the positive vote in today’s European Parliament plenary in favour of engaging in negotiations with the Council. We have witnessed a lively and thorough debate on the Commission’s proposal for the revision of the Tobacco Products proposal, and I would like to thank the MEPs for their support and to pay a special tribute to the rapporteur – Linda McAvan – for her commitment, determination, and important contribution towards securing this favourable vote.
It’s not the end of the road but this will allow us to take the process of negotiations forward and to engage with Council in order to come to a meaningful agreement on the file.
Indeed, the Commission will now carefully analyse the amendments adopted today, and define our position, so that negotiations can continue in trilogue. I am confident that the revised Directive on Tobacco Products can still be adopted within the mandate of the current Parliament. All institutional actors have to play their role since EU citizens expect all of us to act on tobacco and to adopt in the near future a new legislation which will put the EU on the frontline on a global stage”.
Author: ec.europa.eu/health
14.10.2013
When thinking of the risk factors for sudden cardiac death – including high blood pressure, high LDL cholesterol and smoking – most people would not think about how close they live to a major road. But a new study from the American Heart Association suggests that living close to a major road increases the risk of dying from sudden cardiac death for women.
The researchers – led by Jaime E. Hart from Brigham and Women’s Hospital and Harvard Medical School in Boston, MA – publish their findings in the journal Circulation.
According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death for women in the US and killed over 292,000 women in 2009 – accounting for 1 in every 4 female deaths.
Additionally, around 64% of women who die suddenly of coronary heart diseasehave not had any previous symptoms, which means that even in the absence of symptoms, many women may be at risk for heart disease.
„It’s important for health care providers to recognize that environmental exposures may be under-appreciated risk factors for diseases such as sudden cardiac death and fatal coronary heart disease,” says Hart.
As such, he and his colleagues studied data from over 107,000 women who had an average age of 60 and who were mostly white, as part of the Nurses’ Health Study from 1986-2012.
The researchers say previous studies have found a slight increase in coronary heart disease risk among individuals living near major roadways, but theirs is the first to examine the effect of roadway proximity on sudden cardiac death risk.
After calculating the participants’ distance to roadways and adjusting for other factors, the researchers found that living within 50 m (164 ft) of a major road increased sudden cardiac death risk by 38%, compared with those who lived at least 500 m (0.3 miles) away.
Additionally, each 100 m (328 ft) closer a participant lived to major roadways increased her risk for sudden cardiac death by 6%.
„On a population level,” says Hart, „living near a major roadway was as important a risk factor as smoking, diet or obesity.” The researchers note that the Environmental Protection Agency (EPA) reported 35 million people in the US lived within 300 m (984 ft) of a major road in 2009.
Though their study involves a large number of participants, the researchers say they were unable to measure all possible risk factors associated with living near major roadways. As such, they say more research is needed that includes men and women of different ages, races and income levels, given their limitation that most participants were middle-aged or elderly, white and in the middle- and upper-socioeconomic classes.
Author: Medical News Today
14.10.2014
Since the launch of the Action Plan in 2009, most EU countries have recognised the central role of donor transplant coordinators in their transplant system. Depending on the national set-up, donor transplant coordinators help identify potential donors, establish contact with the family of potential donors, liaise with potential recipients and organise the complex logistics from donation to transplantation.
Another positive finding is that the efforts of Member States have led to an increase in deceased donation rates. The EU contributed significantly to this success by co-funding training programmes for donor transplant coordinators under the Public Health Programme.
Most Member States have also set up living donor transplant programmes – an important source for additional organs. Donation of organs from living donors leads to particularly good health outcomes, and these programmes are very well established in a number of EU countries. Successful programmes must protect living donors effectively (medical follow-up). In this respect, the EU has facilitated the sharing of experiences between EU countries, supported them in establishing registers and methodologies to follow-up donors, and developed a manual for authorities setting up living donation programmes.
The report also outlines the work for the remainder of the Action Plan (2014-2015). At European level the focus will be on living donation and the international exchange of organs, in particular organs retrieved in a Member State where they cannot be used. These organs should not be wasted but sent to neighbouring countries for transplantation. Such collaborations may also lead to the development of new transplant programmes where they are not yet available.
At national level the report invites Member States, amongst others, to maintain/increase efforts on donor transplant coordinators, to introduce quality improvement programmes, to improve communication skills of health care professionals and public authorities and to evaluate post-transplant results.
Author:
07.05.2014